牛津纳米孔：伦敦电话分析师活动技术更新凸显了通向更高通量和更低成本的路径，以及在蛋白质传感和临床应用方面的近期潜在应用

Europe Equity Research23 May 2025CAZENOVEwww.jpmorganmarkets.comOxford NanoporeLondon Calling Analyst Event: Tech updates highlight path to higher throughput and lower cost as well as potential near-term applications in protein sensing and clinical usesOverweightONT.L, ONT LNPrice (22 May 25):125pPrice Target (Jun-26):190pEuropean Pharmaceuticals & BiotechnologyJames D Gordon AC(44-20) 7742-6654james.d.gordon@jpmorgan.comRichard Vosser(44-20) 7742-6652richard.vosser@jpmorgan.comZain Ebrahim(44-20) 3493-1163zain.ebrahim@jpmorgan.comJohn Priestner(44-20) 7742-9923john.priestner@jpmorgan.comSophia Graeff Buhl Nielsen(44-20) 7742-3918sophia.graeffbuhlnielsen@jpmorgan.comJ.P. Morgan Securities plcSpecialist Sales contact details:Marjan Daeipour - Specialist Sales - European Healthcare(44 20) 7134-1329marjan.daeipour@jpmorgan.comYesterday, we attended ONT’s London Calling Analyst Event. The company was represented by CEO Gordon Sanghera, CFO Nick Keher, SVP Product and Programme Management R